Immunogenic SARS-CoV-2 Epitopes: In Silico Study Towards Better Understanding of COVID-19 Disease—Paving the Way for Vaccine Development

Immunogenic SARS-CoV-2 Epitopes: In Silico Study Towards Better Understanding of COVID-19 Disease—Paving the Way for Vaccine Development

The emergence of the COVID-19 outbreak at the end of 2019, caused by the novel coronavirus SARS-CoV-2, has, to date, led to over 13.6 million infections and nearly 600,000 deaths. Consequently, there is an urgent need to better understand the molecular factors triggering immune defense against the v...

Full description

Bibliographic Details
Main Authors: Vipin Ranga, Erik Niemelä, Mahlet Z. Tamirat, John E. Eriksson, Tomi T. Airenne, Mark S. Johnson
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Vaccines
Subjects:
SARS-CoV-2
COVID-19
SARS-CoV
in silico analysis
MHC class I epitopes
HLA
Online Access:https://www.mdpi.com/2076-393X/8/3/408

Similar Items

Similar Items